Press Release

Dec, 14 2023

Decoding Intruders: Advanced Techniques for Swift Parasitology Identification in Clinical and Environmental Samples

The global parasitology identification market encompasses a diverse range of diagnostic tools and technologies designed to identify and analyze parasitic infections in humans and animals. With the increasing prevalence of parasitic diseases worldwide, this market has witnessed substantial growth. Advanced molecular techniques, such as PCR and DNA sequencing, alongside traditional microscopy, contribute to accurate and timely identification. As healthcare systems globally prioritize infectious disease management, the demand for reliable and efficient parasitology identification tools is expected to continue growing, shaping the landscape of the global parasitology identification market.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-parasitology-identification-market

Data Bridge Market Research analyses that the Global Parasitology Identification Market, valued at USD 4,092.15 million in 2022, will reach USD 6,522.27 million by 2030, growing at a CAGR of 6% during the forecast period of 2023 to 2030. Collaborations among research institutions, pharmaceutical firms, and diagnostic tool manufacturers drive the creation of innovative parasitology identification solutions, leveraging combined expertise and resources for advancements in diagnosis and treatment.

Key Findings of the Study

Parasitology Identification Market

Integration of artificial intelligence (AI) is expected to drive the market's growth rate

The infusion of artificial intelligence (AI) and machine learning into parasitology identification significantly accelerates diagnostics with heightened precision. This integration appeals to healthcare providers and laboratories, as it not only improves efficiency but also represents a technological leap in the quest for more accurate and timely identification of parasitic infections, ultimately contributing to enhanced patient care and management of parasitological diseases.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Products (Consumables and Accessories, Devices), Methods (Microscopic Identification, Fecal Identification, Immunological Techniques, Morphological Identification, Molecular Techniques, Rapid Diagnostic Tests (RDTs), Maldi-TOF MS, Others), Pathogen Type (Protozoan, Helminths, Arthropodes, Tapeworm, Ectoparast), Sample (Feces, Blood, Urine, Cerebrospinal Fluid (CSF), Serum and Plasma, Others), Stool Concentration and Preparation (Concentration Technique, Un-Concentration Technique), End User (Diagnostic Centers, Hospitals, Clinics, Ambulatory Surgical Centres, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Abbott (U.S.), BD (U.S.), bioMérieux, Inc (France), Bruker (U.S.), Quest Diagnostics (U.S.), Akron Biotech (U.S.), Thermo Fisher Scientific Inc (U.S.), altona Diagnostics GmbH (Germany), Biomerica (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Creative Diagnostics  (U.S.), Luminex Corporation (U.S.), Meridian Bioscience, Inc. (U.S.), R-Biopharm AG (Germany), Shimadzu Corporation (Japan), Institut Virion/Serion (Germany), VWR International, LLC.  (U.S.), Hardy Diagnostics (U.S.), TECHLAB, Inc. (U.S.), Alpha-Tec (U.S.), Medical Chemical Corporation (MCC). (U.S.)

Data Points Covered in the Report

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Segment Analysis:

The global parasitology identification market is segmented on the basis of product, method, pathogen type, sample, stool concentration and preparation, and end user.

  • On the basis of products, the global parasitology identification market is segmented into consumables and accessories and devices
  • On the basis of methods, the global parasitology identification market is segmented into fecal identification, immunological techniques, morphological identification, molecular techniques, rapid diagnostic tests (RDTS), maldi-TOF MS and others
  • On the basis of pathogen type, the global parasitology identification market is segmented into protozoan, helminths and ectoparasties
  • On the basis of sample, the global parasitology identification market is segmented into feces, blood urine, serum and plasma, and others
  • On the basis of stool concentration and preparation, the global parasitology identification market is segmented into concentration technique and unconcentration technique
  • On the basis of end user, the global parasitology identification market is segmented into diagnostic centers, hospitals, clinics and others

 Major Players

Data Bridge Market Research recognizes the following companies as the major global parasitology identification market players in global parasitology identification market are Luminex Corporation (U.S.), Meridian Bioscience, Inc. (U.S.), R-Biopharm AG (Germany), Shimadzu Corporation (Japan), Institut Virion/Serion (Germany), VWR International, LLC.  (U.S.), Hardy Diagnostics (U.S.), TECHLAB, Inc. (U.S.), Alpha-Tec (U.S.), Medical Chemical Corporation (MCC). (U.S.)

Parasitology Identification Market

Market Developments

  • In September , 2020, Zoetis unveiled VETSCAN IMAGYST, a revolutionary diagnostic tool designed for detecting intestinal parasites in pets. This innovative tool utilizes a blend of image recognition technology and cloud-based artificial intelligence to deliver precise testing results. By automating fecal examination, VETSCAN IMAGYST ensures a swift and accurate diagnosis, identifying internal parasite eggs, cysts, and other indicators. Zoetis' launch marks a significant step forward in leveraging technology for enhanced and efficient veterinary diagnostics
  • In August 2020, Shimadzu and Horiba Ltd. entered a collaborative agreement to develop and commercialize LC-Raman analytical and measurement equipment. This innovative technology combines Shimadzu's high-performance liquid chromatographs (LCs) with Horiba's Raman spectrometers. With leading market shares in Japan, the synergistic approach aims to revolutionize medicine, healthcare, life sciences, materials research, and environmental studies. LC-Raman systems integrate efficient sample separation by LCs with qualitative and quantitative chemical measurements by Horiba's Raman spectrometers, offering breakthroughs across various sectors
  • In 2020, Abbott conducted a malaria study in the Mpigi district, employing its latest rapid diagnostic malaria kit alongside the market's standard test. Remarkably, Abbott's quick diagnostic test revealed a doubled positivity rate compared to the standard test, signaling a breakthrough. This outcome not only showcases the efficacy of Abbott's technology but also significantly enhances the company's brand value in the marketplace, solidifying its position as a leader in innovative and reliable diagnostic solutions for malaria
  • In 2020, BD achieved approval for its automated flow cytometer system, the BD FACSDuet. This innovation enhances accuracy and standardization across instruments and operators. Automation solutions, exemplified by BD FACSDuetTM and BD FACSLyricTM Complete Sample-to-Answer Solution, elevate throughput and deliver consistent results. These advancements not only bolster efficiency but also provide clinicians with reliable data crucial for guiding patient care, marking a significant stride in the field of flow cytometry

Regional Analysis

Geographically, the countries covered in the global parasitology identification market report are

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

As per Data Bridge Market Research analysis:

North America is the dominant region in the global parasitology identification market during the forecast period 2023-2030

North America dominates the global parasitology identification market, driven by its status as the largest consumer market and high gross domestic product. The U.S., a key player in the region, is expected to sustain this dominance, experiencing growth in the parasitology identification market during the forecast period. Factors such as escalating healthcare costs, heightened parasitology-related research and development initiatives, and ongoing advancements in diagnostic tools contribute to the anticipated growth, solidifying North America's leadership position.

Asia-Pacific is estimated to be the fastest-growing region in the global parasitology identification market during the forecast period 2023-2030

Asia-Pacific is expected to dominate the global parasitology identification market, experiencing the highest growth rate. This dominance is fueled by the upgradation of medical infrastructure and proactive initiatives from federal bodies. Within the region, China is poised to be a market leader, showcasing rapid product adoption and notable advancements in parasitology identification. The nation's significant contributions position it as a frontrunner in the global landscape of parasitology identification.

For more detailed information about the global parasitology identification market report, click here – https://www.databridgemarketresearch.com/reports/global-parasitology-identification-market


Client Testimonials